0001144204-18-013455.txt : 20180307
0001144204-18-013455.hdr.sgml : 20180307
20180307214630
ACCESSION NUMBER: 0001144204-18-013455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180305
FILED AS OF DATE: 20180307
DATE AS OF CHANGE: 20180307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BFI Co., LLC
CENTRAL INDEX KEY: 0001601607
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 18674892
BUSINESS ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 2013297300
MAIL ADDRESS:
STREET 1: 300 FRANK W. BURR BLVD., STE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
4
1
tv487754_form4.xml
FORM 4
X0306
4
2018-03-05
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001601607
BFI Co., LLC
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666
0
0
1
0
Class A Common Stock
2018-03-05
4
C
0
36000
0
A
72000
D
Class A Common Stock
2018-03-05
4
S
0
5134
38.97
D
66866
D
Class A Common Stock
2018-03-05
4
S
0
6866
39.64
D
60000
D
Class A Common Stock
2018-03-06
4
S
0
10600
38.69
D
49400
D
Class A Common Stock
2018-03-06
4
S
0
1400
39.18
D
48000
D
Class A Common Stock
2018-03-07
4
S
0
12000
38.92
D
36000
D
Class B Common Stock
0
2018-03-05
4
C
0
36000
0
D
Class A Common Stock
36000
20516034
D
Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.40 to $39.35, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.40 to $40.13, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.05 to $39.55, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.45 to $39.45, inclusive.
/s/ Thomas G. Dagger, as Attorney-in-Fact for BFI Co., LLC
2018-03-07